Moreover, subsequent studies have confirmed the crucial role of EPH/ephrin signaling in the medulloblastoma metastatic capacity; EPHB2 and ephrin-B1—except for being overexpressed—were also found to associate with invasive and metastatic tumor subtypes [67]. This evidence concerns the gene EPHB2 and medulloblastoma.